Rep. April McClain Delaney Purchases Shares of STERIS plc (NYSE:STE)

Posted by Max Byerly on Apr 10th, 2026

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of STERIS plc (NYSE:STE). In a filing disclosed on April 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in STERIS stock on March 16th.

Representative April McClain Delaney also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of Entegris (NASDAQ:ENTG) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Somnigroup International (NYSE:SGI) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Rollins (NYSE:ROL) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Nasdaq (NASDAQ:NDAQ) on 3/31/2026.
Sold $1,001 – $15,000 in shares of Bio-Techne (NASDAQ:TECH) on 3/26/2026.
Purchased $1,001 – $15,000 in shares of Packaging Corporation of America (NYSE:PKG) on 3/20/2026.
Purchased $1,001 – $15,000 in shares of Nasdaq (NASDAQ:NDAQ) on 3/18/2026.
Purchased $1,001 – $15,000 in shares of Packaging Corporation of America (NYSE:PKG) on 3/17/2026.
Purchased $1,001 – $15,000 in shares of Somnigroup International (NYSE:SGI) on 3/16/2026.

STERIS Price Performance

STE opened at $223.32 on Friday. The firm has a market capitalization of $21.90 billion, a PE ratio of 31.15 and a beta of 1.07. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75. The business’s 50-day moving average is $235.27 and its two-hundred day moving average is $246.99. STERIS plc has a 1 year low of $209.98 and a 1 year high of $269.44.

STERIS (NYSE:STE – Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. During the same period in the previous year, the company posted $2.32 EPS. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th were paid a $0.63 dividend. This represents a $2.52 annualized dividend and a yield of 1.1%. The ex-dividend date was Tuesday, February 17th. STERIS’s payout ratio is 35.15%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on STE. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 28th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Six equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $275.20.

Read Our Latest Report on STERIS

Insider Activity at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the company’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the sale, the director directly owned 705 shares of the company’s stock, valued at $167,233.05. This represents a 81.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.07% of the stock is owned by company insiders.

Institutional Trading of STERIS

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Steigerwald Gordon & Koch Inc. purchased a new position in shares of STERIS in the third quarter worth about $25,000. Board of the Pension Protection Fund acquired a new position in STERIS in the 4th quarter worth approximately $25,000. Harbor Investment Advisory LLC increased its holdings in STERIS by 115.4% in the 4th quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 60 shares during the period. Activest Wealth Management raised its position in STERIS by 423.8% during the 4th quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 89 shares during the last quarter. Finally, Measured Wealth Private Client Group LLC purchased a new position in STERIS during the 4th quarter worth approximately $28,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

About STERIS

(Get Free Report)

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.